Libtayo: Uses, Side Effects, Warnings - Drugs. com Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer Includes Libtayo side effects, interactions and indications
LIBTAYO® (cemiplimab-rwlc) in Advanced NSCLC, BCC, CSCC . . . LIBTAYO is a prescription medicine used to treat adults with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI
Regenerons Libtayo stakes out new territory in skin cancer Regeneron's Libtayo has become the first checkpoint inhibitor to be cleared by the FDA as an adjuvant treatment for adults with cutaneous squamous cell carcinoma (CSCC) – a form of skin cancer
What Is Libtayo Used For in Skin and Lung Cancer Libtayo is an immunotherapy drug approved for certain skin and lung cancers Learn how it works, what conditions it treats, and what to expect during treatment
Immunotherapy for Advanced Basal or Squamous Cell Skin Cancers Immunotherapy is the use of medicines to stimulate a person’s own immune system to recognize and destroy cancer cells more effectively Some types of immunotherapy can be used to treat people with advanced basal cell carcinoma (BCC) or squamous cell carcinoma (SCC) of the skin